Primary Cells Market Overview
Primary human cells are necessary for some medical purposes like researches. Market Research Future (MRFR) has published a research report about the global primary cells market that has predicted significant growth with 8.13% CAGR (Compound Annual Growth Rate) for this market between 2020 and 2027. The key factors that drive this market are growing cancer research, increasing demand for monoclonal antibodies, rapid growth in biotechnology and biopharmaceutical industries, rising healthcare expenditure, and various other advantages. However, factors that can obstruct the growth of this market include the high cost of advanced primary cells and risk of contamination.
The global Primary Cells Market has been segmented on the basis of the end user, origin, type, and lastly region. Based on end users, this market has been segmented into research institutes and life science research companies. On the basis of origin, the market has been segmented into gastrointestinal cells, hematopoietic cells, heart cells, liver cells, lung cells, renal cells, skeletal and muscle cells, skin cells, and others. By type, the market has been segmented into animal; primary and human primary cells. Animal primary cells are isolated and purified from qualified laboratory animal tissues. Primary human cells are directly cultured from their source organ tissue or blood cells.
Increased research activities focused on biopharmaceutical discovery and biotechnology, increased investment in cancer research, growing demand for monoclonal antibodies and higher healthcare expenditure are some of the key factor influencing the global primary cells market. Primary human cells are preferred over cell lines which also remains a positive factor. Unlike endothelial cell lines, endothelial cells retain most functional markers. Primary cells being a novel technology is relatively more expensive. At the same time, issue of cell contamination is yet to be effectively addressed.
Primary Cells Market Segmentation
MRFR’s report includes an in-depth segmental analysis of the global primary cell market based on type, origin and end user.
Based on type, the market has been segmented into animal primary cells and human primary cells. Based on origin, the market has been segmented into hematopoietic cells, liver cells, renal cells, skeletal and muscle cells, skin cells, gastrointestinal cells, lung cells, heart and others. Based on end-user, the market has been segmented into life science research companies and research institutes.
Primary Cells Market Regional Analysis
Based on region, the market has been segmented into Europe, Americas, the Middle East and Africa (MEA), and Asia Pacific (APAC). The Americas cells market cover both South America and North America. The Europe primary cells market covers Eastern Europe and Western Europe. Key countries covered in the Asia Pacific primary cells market include China, South Korea, Japan, Australia, and India. In terms of revenue, North America and South America collectively dominate the global primary cells market. Some of the key factors supporting the growth of the market in Americas include strong government backing for R&D, easy access to latest medical technologies and increased prevalence of cancer. Data released by National Cancer Institute revealed that nearly 1,685,210 new cases of cancer were recorded in the US in 2016.
Europe in holds the second spot in terms of value. Healthcare remains a major area of focus for the EU. Over the years, several policies have been launched to improve health care services in the region. Advanced countries in Europe present attractive growth opportunities for market players. In 2016, the gross domestic expenditure on R&D activities was more than Euro 33 Bn as per the office for National Statistics.
APAC is viewed as an emerging market for primary cells. The healthcare sector in APAC is witnessing tremendous growth, which is translating into opportunities for market players. Rising number of cancer cases, introduction favourable policies and pharmaceutical outsourcing are some of the factors supporting the market growth in APAC. Spending on medical science R&D institutes have surged in countries such as China and India, which is paving the way for the market to growth. The market in MEA is also expected to grow at a healthy pace but from a lower base. Many of the countries in MEA face issues such as underdeveloped healthcare infrastructure, limited access to services, etc.
Primary Cells Market Players
- AllCells (US)
- ZenBio Inc. (Research Triangle Park NC)
- PromoCell (UK)
- Thermo Fisher Scientific Inc. (US)
- Cell Biologics Inc. (Chicago)
- STEMCELL Technologies Inc. (Canada)
- Merck KGaA (Germany)
- American Type Culture Collection (ATCC)
- AG (Switzerland)
- Others
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/primary-cells-market-6296
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
